节点文献

DNA拓扑异构酶Ⅱ与抗肿瘤药物靶点的研究进展

New research approaches in DNA topoisomerase Ⅱ targets and antitumor drug

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 崔兴张会平侯仰韶徐瑞荣

【Author】 Cui Xing ,et al. Shandong University Of Traditional Chinese Medical,250014

【机构】 山东中医药大学山东中医药大学附属医院 2002级研究生 2500142002级研究生 250014250011

【摘要】 DNA拓扑异构酶Ⅱ(TopoisomeraseⅡ,TopoⅡ)是一种真棱生物生存所必需的泛酶,在几乎所有DNA代谢过程中发挥重要作用。因为TopoⅡ具有重要的生理功能,它已成为抗癌药物的重要作用靶点。近年来,对TopoⅡ催化机制和药物作用方式的研究取得了很大进展,这些发现有助于进一步了解TopoⅡ的生理功能,进而研究出更有效的治疗方案和新的抗癌药。本文介绍了以TopoⅡ为靶点的抗癌药物的作用机制及其发展现状。

【Abstract】 DNA topoisomerase Ⅱ(Topo Ⅱ)is a ubiquitous enzyme that is essential for survival of the eukaryotic organisms , playing an important role in most processes of the DNA mechanisms. In addition to its critical cellular functions, Topo Ⅱ is an important target for a number of the most active and widely prescribed anticancer drugs. Over the past several years , great progress has been made in the catalytic mechanisms of Topo Ⅱand the mechanism of action of drugs targeting this enzyme. These advances have provided novel insight into the physiological functions of Topo Ⅱ and have led to the development of more efficacious chemotherapeutic regimens and new anticancer drugs. The anti-cancer mechanism of Topo Ⅱ inhibitors and the status of development are introduced in this review.

  • 【文献出处】 青岛医药卫生 ,Qingdao Medical Journal , 编辑部邮箱 ,2004年06期
  • 【分类号】R96
  • 【被引频次】10
  • 【下载频次】588
节点文献中: 

本文链接的文献网络图示:

本文的引文网络